PEER-REVIEWED
PUBLICATIONS
Biopharmaceutical Bioethics & Organizational Ethics Peer-Reviewed Publications
Considerations for applying bioethics norms to a biopharmaceutical industry setting
Development, implementation and critique of a bioethics framework for pharmaceutical sponsors of human biomedical research
Eli Lilly and Company’s Bioethics Framework for Human Biomedical Research
Expanded access programs: Ethical and practical considerations for biopharmaceutical sponsors
A pharmaceutical bioethics consultation service: Six-year descriptive characteristics and results of a feedback survey
Clinical use of amyloid-PET neuroimaging: Practical and bioethical considerations
Developing good scientific publishing practices: One pharmaceutical company’s perspective
Incorporating ethical principles into clinical research protocols: a tool for protocol writers and ethics committees
-
A systematic approach to bioethics in a biopharmaceutical company
Van Campen LE, Watson SB, Klopfenstein M, Turik MA
World Congress of Bioethics, Edinburgh, Scotland, June 2016MRCT Center framework for post-trial responsibilities (PTR) to research participants: Continued access to investigational medicines
Van Campen, LE, Li L, Aldinger C, Bierer BE, on behalf of the MRCT Center Working Group on Post-Trial Responsibilities
World Congress of Bioethics, Edinburgh, Scotland, June 2016The role of bioethics in the pharmaceutical industry: Informal review of 5-year trends and one company’s systematic approach
Van Campen LE, Therasse DG
Public Responsibility in Medicine and Research Annual Meeting, Boston, MA, November, 2015A biopharmaceutical company’s bioethics position on pediatric drug and device development
Allen AJ, Watson SB, Van Campen LE, Short MA
Annual meeting of the American Society of Bioethics and Humanities, San Diego, California, October 2015Clinical use of amyloid PET neuroimaging: Practical and bioethical considerations
Witte MM, Foster NL, Fleisher AS, et al, including Van Campen LE
Annual meeting of the American Academy for Geriatric Psychiatry, New Orleans, LA, March 2015Bioethics capacity building in a corporate setting: One pharmaceutical company’s experience
Moderator: LE Van Campen; Presenters: DG Therasse, TL Beauchamp, RJ Levine
American Society for Bioethics and Humanities 15th Annual Meeting, Atlanta, Georgia, October 25, 2013. -
International Human Biomedical Research Ethics
Regulatory Science for Scientists, Engineers and Managers Course
University of Michigan
Ann Arbor, MI, Annually 2010-2019An Introduction to Biopharmaceutical Bioethics
Bioethics Intensive Course
Trinity International University
Deerfield, IL, June 17, 2019Bioethics for Drug Development
Drug Discovery and Development Course
Purdue University
West Lafayette, IN, February 2017-2019Introduction to Bioethics Deliberations and Decision-Making
Biopharmaceutical Industry Bioethics Forum Annual Summit
Boston, MA, August 22, 2018Bioethics in the Bio-Pharmaceutical Industry: A Glimpse of Bioethics in a Different Setting
Plenary Panel
Public Responsibility in Research and Medicine (PRIM&R) Advancing Ethical Research Conference
San Antonio, TX, November 8, 2017Post-Trial Access: Terminology and Ethical Concepts Matter
Panel Session – “Post-trial Access: Ensuring Patient Access Across the Development Spectrum”
Drug Information Association (DIA) Annual Meeting
Chicago, IL, June 20, 2017Multinational Biomedical Research Ethics
McWhirter Conference – “BioEthics – Who Decides?”
Newnham College, Cambridge University
Cambridge, England, March 29, 2017Post-trial Responsibilities to Research Participants
Brigham and Women’s and Harvard Multi-regional Clinical Trials (MRCT) Center Annual Meeting
Cambridge, MA, December 2015Session VIII Panel. Future vision: Ethics and policy lens
Bioethics Colloquium – “Pre-approval Access: Can Compassion, Business, and Medicine Coexist?”
NYU School of Medicine and the New York Academy of Sciences
New York, NY, October 2015Case Study Panel Discussion
Harvard Multi-regional Clinical Trials (MRCT) Center Conference on Post-trial Ethical Responsibilities
Cambridge, MA, September 18, 2014